A study of the COVID-19 sequlae
Not Applicable
- Conditions
- COVID-19
- Registration Number
- JPRN-UMIN000041168
- Lead Sponsor
- The Japanese Respiratory Society
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 1000
Inclusion Criteria
Not provided
Exclusion Criteria
Patients under the age of 20 Cases judged by the attending physician to be ineligible
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Actual condition of sequelae such as deterioration of lung function after COVID-19 1.Changes in pulmonary function tests (FVC, DLCO, TLC, etc.). 2.Lung volume pred Total lung capacity ratio in Chest CT scan 3. Subjective symptoms (shortness of breath: mMRC, olfaction, dysgeusia, malaise, headache, fever, chronic fatigue syndrome diagnostic criteria, Pittsburgh sleep questionnaire, etc.) 4. Changes in chest CT (HRCT) findings
- Secondary Outcome Measures
Name Time Method 1. Search for factors (including biomarkers) that predict lung dysfunction and other sequelae 2.The actual condition survey of rehabilitation for sequlae of COVID-19 Reality